Supraspinal Contributions to the Control of Human Locomotion: Clinical and Fundamental Aspects
NCT ID: NCT02263560
Last Updated: 2017-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2014-03-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators want to test the hypothesis that during simple goal-oriented locomotor tasks, only patients with specific (e.g. medio or infero- temporal) lesions will express navigational deficits.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Post-stroke patients
Patients who experienced stroke and who already recover gait abilities.
Kinematic measurements
Control population
Participants matching the criterion (age and gender) of the patients' group.
Kinematic measurements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kinematic measurements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Persons injured at the time of the experiments (fractures,…);
* Persons having reported repetitive spatial troubles/disorders;
* Persons with eye disorders and non-corrected vision problems;
* Pregnant women.
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr Titus Bihl, Hopital Cantonal Fribourgeois
UNKNOWN
University of Fribourg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Halim HICHEUR
Lecturer (PhD)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University (UNIFR) and Hospital of Fribourg (HFR)
Fribourg, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UFribourg
Identifier Type: -
Identifier Source: org_study_id